
Sign up to save your podcasts
Or
Host Shawn McNeil, MD, is joined by Michelle Lofwall, MD, DFAPA, DFASAM, a professor in the Department of Behavioral Science and Psychiatry at the University of Kentucky and Medical Director of UK’s Robert Straus and First Bridge Clinics, which provide comprehensive OUD treatment within the UK Center on Drug and Alcohol Research. Dr. Lofwall and her co-authors examined the relationship between the dose in the early stages of treatment and the subsequent risk of death and found some surprising results.
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
Journal of Addiction Medicine 18(3):p 319-326, 5/6 2024
May-June 2024
4.8
3030 ratings
Host Shawn McNeil, MD, is joined by Michelle Lofwall, MD, DFAPA, DFASAM, a professor in the Department of Behavioral Science and Psychiatry at the University of Kentucky and Medical Director of UK’s Robert Straus and First Bridge Clinics, which provide comprehensive OUD treatment within the UK Center on Drug and Alcohol Research. Dr. Lofwall and her co-authors examined the relationship between the dose in the early stages of treatment and the subsequent risk of death and found some surprising results.
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality
Journal of Addiction Medicine 18(3):p 319-326, 5/6 2024
May-June 2024
129 Listeners
12,103 Listeners
706 Listeners
281 Listeners
1,321 Listeners
290 Listeners
562 Listeners
4,476 Listeners
317 Listeners
44 Listeners
122 Listeners
33 Listeners
8 Listeners
175 Listeners
112 Listeners